Single pretransplant bolus of recombinant activated factor VII ameliorates influence of risk factors for blood loss during orthotopic liver transplantation

Pediatric Transplantation

Volumn 9, Issue 3, 2005, Pages 299-304

  Kaliciński, Piotr ^a   Markiewicz, Małgorzata ^a   Kamiński, Andrzej ^a   Łaniewski, Przemysław ^a   Ismail, Hor ^a   Drewniak, Tomasz ^a   Szymczak, Marek ^a   Nachulewicz, Paweł ^a   Jezierska, Elzbieta ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Blood loss; Coagulopathy; Liver transplantation; RFVIIa

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTENSIVE CARE; LIVER TRANSPLANTATION; LIVER VEIN THROMBOSIS; OPERATION DURATION; PARTIAL THROMBOPLASTIN TIME; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; RISK FACTOR; THROMBOSIS;

ADOLESCENT; ADULT; BLOOD LOSS, SURGICAL; CHILD; CHILD, PRESCHOOL; FACTOR VIIA; HUMANS; INFANT; INTERNATIONAL NORMALIZED RATIO; LIVER TRANSPLANTATION; RECOMBINANT PROTEINS; RISK FACTORS;

EID: 20344393641     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00309.x     Document Type: Article

References (20)

1. HENDRIKS HG, VAN DER MEER J, KLOMPMAKER IJ, et al. Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagul Fibrinolysis 2000: 11(Suppl. 1): S87-93.
2. GERLACH H, SLAMA KJ, BECHSTEIN WO, et al. Retrospective statistical analysis of coagulation parameters after 250 liver transplantations. Semin Thromb Hemost 1993: 19: 223-232.
3. PALOMO SANCHEZ JC, JIMENEZ C, MORENO GONZALES E, et al. Effects of intraoperative blood transfusion on postoperative complications and survival after orthotopic liver transplantation. Hepatogastroenterology 1998: 45: 1026-1033.
4. CACCIARELLI TV, KEEFFE EB, MOORE DH, et al. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg 1999: 134: 25-29.
5. MOR E, JENNINGS L, GONWA TA, et al. The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet 1993: 176: 219-227.
6. OZIER YM, LE CAM B, CHATELLIER G, et al. Intraoperative blood loss in pediatric liver transplantation: analysis of preoperative risk factors. Anesth Analg 1995: 81: 1142-1147.
7. HEDNER U, ERHARDTSEN E. Potential role for rFVIIa in transfusion medicine. Transfusion 2002: 42: 114-124.
8. SHAMI VM, CALDWELL SH, HESPENHEIDE EE, ARSENEAU KO, BICKSTON SJ, MACIK BG. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transplant 2003: 9: 138-143.
9. CHUANSUMTIT A, TREEPONGKARUNA S. Combined fresh frozen plasma with rFVIIa in restoring hemostasis for invasive procedures in children with liver disease. Thromb Haemost 2001: 85: 748-749.
10. BERNSTEIN D. Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced child's B and C cirrhosis. Semin Thromb Hemost 2000: 26: 437-438.
11. KALICINSKI P, KAMINSKI A, DREWNIAK T, et al. Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII. Transplant Proc 1999: 31: 378-379.
12. STEIB A, FREYS G, LEHMANN C, MEYER C, MAHOUDEAU G. Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anesth 2001: 48: 1075-1079.
13. MOTSCHMAN TL, TASWELL HF, BRECHER ME, et al. Intraoperative blood loss and patient and graft survival in orthotopic liver transplantation: their relationship to clinical and laboratory data. Mayo Clin Proc 1989: 64: 346-355.
14. KANG Y. Coagulopathies in hepatic disease. Liver Transplant 2000: 6: S72-S75.
15. MARKIEWICZ M, KALICINSKJ P, KAMINSKI A, et al. Acute coagulopathy after reperfusion of the liver graft in children - correction with recombinant activated factor VII. Transplant Proc 2003: 35: 2318-2319.
16. FINDLAY JY, RETTKE SR, ERETH MH, PLEVAK DJ, KROM RAF, KUFNER RP. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study. Liver Transplant 2001: 7: 802-807.
17. HENDRIKS HG, MEIJER K, DE WOLF JT, et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation. Transplantation 2001: 71: 402-405.
18. HENDRIKS HG, MEIJER K, DE WOLF JT, et al. Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation. Blood Coagul Fibrinolysis 2002: 13: 309-313.
19. CACCIARELLI TV, KEEFFE EB, MOORE DH, et al. Primary liver transplantation without transfusion of red blood cells. Surgery 1996: 120: 698-704.
20. MEIJER K, HENDRIKS HG, DE WOLF JT, et al. Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis. Blood Coagul Fibrinolysis 2003: 14: 169-174.